tirzepatide after pregnancy Weight Loss Weaning Tirzepatide and Pregnancy: Safety, Risks,

Members looking for an easy-to-use format that doesn't involve injections or droppers, particularly those just starting their weight management journey

Ongoing monitoring and regular consultations with healthcare providers are important

It is not recommended during pregnancy or breastfeeding, and treatment should usually be stopped at least two months before planning a pregnancy

A 2018 review article comparing GLP-1 receptor agonists reported that, in studies, semaglutide 1 mg once weekly resulted in a mean weight loss from 4.53 to 6.5 kg, while dulaglutide at 1.5 mg once weekly resulted in a mean weight loss from 0.87 to 3.03 kg